Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas.

Maucort-Boulch D, Djeridane M, Roy P, Riche B, Colonna P, Andrieu JM.

Cancer. 2007 Jan 15;109(2):256-64.

2.

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.

Ai Zheng. 2006 Aug;25(8):1013-8. Chinese.

PMID:
16965685
3.
4.

[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.

Ai Zheng. 2007 Dec;26(12):1360-4. Chinese.

PMID:
18076802
5.

[Treatment results of Hodgkin's lymphoma].

Aleknavicius E, Valuckas KP, Aleknaviciene B, Norkiene L, Smailyte G.

Medicina (Kaunas). 2009;45(8):615-23. Lithuanian.

6.

[Long term results for intermediate and high grade localized non Hodgkin lymphoma, treated with chemotherapy and radiotherapy].

Ramírez V P, Ocqueteau T M, Alvarez Z M, Bertín C-M P, Lira V P, Bustos C M, Besa de C P.

Rev Med Chil. 2006 Nov;134(11):1409-16. Epub 2007 Jan 2. Spanish.

7.

Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.

Koumarianou AA, Xiros N, Papageorgiou E, Pectasides D, Economopoulos T.

Anticancer Res. 2007 Mar-Apr;27(2):1191-7.

8.

Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.

Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.

J Clin Oncol. 2003 May 15;21(10):2026-33.

PMID:
12743158
9.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.

Oral Oncol. 2008 Jan;44(1):23-30. Epub 2007 Feb 15.

PMID:
17306611
10.

Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.

Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I.

Bone Marrow Transplant. 2007 Oct;40(7):651-8. Epub 2007 Jul 30.

PMID:
17660837
11.

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

Glimelius I, Molin D, Amini RM, Gustavsson A, Glimelius B, Enblad G.

Eur J Haematol. 2003 Nov;71(5):327-33.

PMID:
14667195
12.

Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.

Sieniawski M, Franklin J, Nogova L, Glossmann JP, Schober T, Nisters-Backes H, Diehl V, Josting A.

J Clin Oncol. 2007 May 20;25(15):2000-5. Epub 2007 Apr 9.

PMID:
17420510
13.

Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?

Laskar S, Bahl G, Muckaden MA, Nair R, Gupta S, Bakshi A, Gujral S, Shet T, Shrivastava SK, Dinshaw KA.

Cancer. 2007 Aug 15;110(4):816-23.

14.

Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.

Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M; Dokuz Eylül Lung Cancer Study Group.

J BUON. 2006 Jan-Mar;11(1):31-7.

PMID:
17318949
15.

How to define intermediate stage in Hodgkin's lymphoma?

Gisselbrecht C, Mounier N, André M, Casanovas O, Reman O, Sebban C, Divine M, Brice P, Briere J, Hennequin C, Fermé C.

Eur J Haematol Suppl. 2005 Jul;(66):111-4.

PMID:
16007878
16.
17.

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.

Visco C, Nadali G, Vassilakopoulos TP, Bonfante V, Viviani S, Gianni AM, Federico M, Luminari S, Peethambaram P, Witzig TE, Pangalis G, Cabanillas F, Medeiros LJ, Sarris AH, Pizzolo G.

Eur J Haematol. 2006 Nov;77(5):387-94. Epub 2006 Jul 27.

PMID:
16879607
18.

Hodgkin lymphoma in Tyrol-a population-based study.

Fong D, Steurer M, Greil R, Gunsilius E, Spizzo G, Gastl G, Tzankov A.

Ann Hematol. 2009 May;88(5):449-56. doi: 10.1007/s00277-008-0618-1. Epub 2008 Oct 10.

PMID:
18846373
19.

[Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].

Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.

Ai Zheng. 2006 Dec;25(12):1543-9. Chinese.

PMID:
17166383
20.

Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.

Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Barbounis A, Grigorakis V, Karkantaris C, Anargyrou K, Chatziioannou M, Rombos J, Boussiotis VA, Vaiopoulos G, Kittas C, Pangalis GA.

Eur J Haematol. 2001 Nov-Dec;67(5-6):279-88.

PMID:
11872075

Supplemental Content

Support Center